Clinical Trials Logo

Allergic Conjunctivitis clinical trials

View clinical trials related to Allergic Conjunctivitis.

Filter by:

NCT ID: NCT00818805 Completed - Clinical trials for Allergic Conjunctivitis

Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)

Start date: July 2008
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy of olopatadine 0.1% using the OHIO Chamber in patients with seasonal allergic conjunctivitis.

NCT ID: NCT00775658 Completed - Allergic Rhinitis Clinical Trials

Olopatadine Eye Drops and Allergy Skin Testing

Start date: January 2008
Phase: N/A
Study type: Interventional

Use of olopatadine ophthalmic solution (eye drops) will decrease allergy skin test reactivity.

NCT ID: NCT00770133 Completed - Clinical trials for Allergic Conjunctivitis

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.

Start date: February 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to establish the safety and efficacy of ketotifen/naphazoline ophthalmic solution compared to vehicle and its individual components in alleviating the signs and symptoms of conjunctival allergen challenge (CAC)-induced allergic conjunctivitis.

NCT ID: NCT00769886 Completed - Clinical trials for Allergic Conjunctivitis

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.

Start date: October 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to establish the safety and efficacy of ketotifen/naphazoline ophthalmic solution compared to vehicle and its individual components in alleviating the signs and symptoms of conjunctival allergen challenge (CAC)-induced allergic conjunctivitis.

NCT ID: NCT00689078 Completed - Clinical trials for Allergic Conjunctivitis

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

Start date: May 2008
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy of prednisolone acetate 1% ophthalmic suspension as compared to prednisolone acetate 0.12% ophthalmic suspension, loteprednol etabonate 0.2% ophthalmic suspension, and placebo (Tears Naturale® II) in the prevention of the signs and symptoms of allergic conjunctivitis. Comparisons will be made following 1 week of twice daily (BID) dosing and 1 week of four times daily (QID) dosing.

NCT ID: NCT00609128 Completed - Clinical trials for Allergic Conjunctivitis

Effect of Olopatadine on Allergic Tear Mediators

Start date: September 2000
Phase: N/A
Study type: Interventional

The purpose of the research is to determine which inflammatory substances are involved in causing allergic symptoms in the eye. Allergic conjunctivitis is a common problem with symptoms of temporary redness, itching, tearing, and swelling of the eyes. Substances released by cells in the affected tissues cause allergic reactions in the eye and elsewhere in the body.

NCT ID: NCT00586664 Completed - Clinical trials for Allergic Conjunctivitis

Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis

Start date: October 2007
Phase: Phase 3
Study type: Interventional

Efficacy and safety study of bepotastine besilate ophthalmic solution in allergic conjunctivitis

NCT ID: NCT00586625 Completed - Clinical trials for Allergic Conjunctivitis

Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

Start date: October 2007
Phase: Phase 3
Study type: Interventional

Safety study for bepotastine besilate ophthalmic solution in normal volunteers

NCT ID: NCT00574379 Completed - Clinical trials for Seasonal Allergic Rhinitis

Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR

Start date: December 2007
Phase: Phase 2
Study type: Interventional

Evaluate the relative efficacy of four dosing regimens of bilastine tablets (given either once or twice per day) versus placebo in patients with Seasonal Allergic Rhinitis (SAR) in the Mountain Cedar season in south Texas and Oklahoma based on the mean change from baseline in Reflective Total Nasal Symptom Scores (TNSS) assessed over 14 days of treatment.

NCT ID: NCT00569777 Completed - Clinical trials for Allergic Conjunctivitis

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

Start date: October 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of a novel contact lens in healthy normal volunteers